Given investment horizon of 30 days, Columbia Laboratories Inc. is expected to under-perform the Adamis. But the stock apears to be less risky and, when comparing its historical volatility, Columbia Laboratories Inc. is 2.89 times less risky than Adamis. The stock trades about -0.07 of its potential returns per unit of risk. The Adamis Pharmaceuticals Corporation is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 71.00 in Adamis Pharmaceuticals Corporation on April 25, 2012 and sell it today you would lose (8.00) from holding Adamis Pharmaceuticals Corporation or give up 11.27% of portfolio value over 30 days.
Diversification
Significant diversification
Overlapping area represents amount of risk that can be diversified away by holding Columbia Laboratories Inc. and Adamis Pharmaceuticals Corp. in the same portfolio (assuming nothing else is changed)
97% of all equities and portfolios perform better than Adamis Pharmaceuticals Corporation. Compared with the overall equity markets, risk-adjusted returns on investments in Adamis Pharmaceuticals Corporation are ranked lower than 3 (%) of all global equities and portfolios over the last 30 days.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
